πŸ‡ΊπŸ‡Έ FDA
Patent

US 12006298

Polymorphic compounds and uses thereof

granted A61PA61P27/02

Quick answer

US patent 12006298 (Polymorphic compounds and uses thereof) held by Aldeyra Therapeutics, Inc. expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Aldeyra Therapeutics, Inc.
Grant date
Tue Jun 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P27/02